This content is from: Patents

In-house IP roundup: SPC waiver will drive innovator investment in secondary patents; EU vote on driverless cars is disastrous for licensing budgets

Managing IP rounds up the latest news and analysis from patent-focused businesses

Drugs

Innovators: SPC waiver may drive investment in secondary patents

UCB, GSK and other innovator drug firms explain how the EU’s SPC Manufacturing Waiver might drive larger investments in secondary patent fortresses for new products and strain resources on monitoring and litigation as they seek to interpret the legislation. Read more ...



Money

EU vote on Wi-Fi for driverless cars is disastrous for licensing budgets, say in-house counsel

Telecoms and automotive firms say that proposed EU legislation to adopt Wi-Fi as the standard for driverless cars will force automotive makers to use an outdated technology and put them at a competitive disadvantage to the rest of the world. Read more ...



UK Actavis ruling raises clarity on dosage regimen patents, say drug companies

Medicine access pressure raises injunction considerations for innovators

As governments face growing concern over rising drug prices, in-house counsel from innovator and generic pharmaceutical companies re-examine their strategies when it comes to injunctions. Read more ...




Money

Prosecution highway drives filing efficiencies but hinders claim flexibility

The Patent Prosecution Highway is gaining popularity because of its cost-saving benefits, but it is not always the right tool for the job, according to in-house counsel. Read more ...


The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2020 Euromoney Institutional Investor PLC. For help please see our FAQs.

Related

Instant access to all of our content. Membership Options | One Week Trial